Naturally, therapeutic blockade of inflammatory cell infiltration and cancer cell metastasis via VCAM-1 has been posed as an intriguing strategy for a range of inflammatory and cancerous pathologies, including colorectal diseases. Here, VCAM1 is linked to cancer.